Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Adverum Biotechnologies, Inc. | AVU | Oct 28, 2024 | 14.80 | 0.00 |
ADVINI S.A. INH. EO 2 | 75V | Oct 28, 2024 | 14.40 | 0.00 |
Adways Co. Ltd | A02 | Oct 28, 2024 | 1.91 | +1.06 |
ADX Energy Ltd | GHU | Oct 28, 2024 | 0.06 | -18.27 |
ADYEN N.V. EO-,01 | 1N8 | Oct 28, 2024 | 1 444.20 | +1.92 |
Adyen N.V. Unsponsored ADR (Netherlands) | 1N8U | Oct 28, 2024 | 14.30 | +2.88 |
Adyton Resources Corporation | 701 | Oct 28, 2024 | 0.10 | -7.21 |
AECI Ltd | A7Z | Oct 28, 2024 | 4.94 | -0.40 |
AECOM | E6Z | Oct 28, 2024 | 96.00 | 0.00 |
Aecon Group Inc. | 2AE | Oct 28, 2024 | 15.00 | +0.67 |
Aedas Homes S.A.U. | 1QK | Oct 28, 2024 | 26.10 | +1.56 |
Aedifica SA | AOO | Oct 28, 2024 | 60.30 | 0.00 |
Aeffe | 3A1 | Oct 28, 2024 | 0.80 | -3.60 |
AEGA ASA NK 1 | 82T0 | Oct 28, 2024 | 0.03 | +51.96 |
Aegean Airlines S.A. | 32A | Oct 28, 2024 | 10.10 | -1.27 |
Aegirbio | 52Q | Oct 28, 2024 | 0.02 | -9.25 |
Aegis Brands Inc. | 6I9 | Oct 28, 2024 | 0.25 | +4.24 |
AEGON LTD. | J060 | Oct 28, 2024 | 5.90 | +0.48 |
Aegon N.V ADR | J06 | Oct 28, 2024 | 5.80 | -1.69 |
Aehr Test Systems | AYB | Oct 28, 2024 | 14.62 | -9.47 |
Aelis Farma S.A. | 69O | Oct 28, 2024 | 3.54 | +1.14 |
Aemetis, Inc | DW51 | Oct 28, 2024 | 2.70 | -0.88 |
Aena S.M.E. S.A. | A44 | Oct 28, 2024 | 205.00 | +0.39 |
Aena SME S.A. American Depositary Receipts - Unsponsored | A440 | Oct 28, 2024 | 19.60 | +1.03 |
AEON CO. LTD ADR/1 O.N. | JUS | Oct 28, 2024 | 21.60 | +0.93 |
Aeon Co. Ltd. | JUS1 | Oct 28, 2024 | 22.60 | +0.89 |
Aeon Financial Service Co Ltd. | 67J | Oct 28, 2024 | 7.15 | 0.00 |
Aeon Mall Co | 9DH | Oct 28, 2024 | 12.00 | 0.00 |
Aeon Metals Limited | D6V1 | Oct 28, 2024 | 0.00 | 0.00 |
AEON REIT INVESTMEN.CORP. | HB0 | Oct 28, 2024 | 756.30 | -0.32 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.